FDA approved orphan drugs with non-orphan indications 1983-2018

Published by
Matej Mikulic,
Jul 22, 2019
This statistic depicts the percentage of FDA-approved orphan drugs with and without additional non-orphan indications between 1983 and 2018. According to the data, in 2017, 14 percent of approved orphan drugs also had additional non-orphan indications.

Percentage of FDA-approved orphan drugs with additional non-orphan indications between 1983 and 2018

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

October 2018

Region

United States

Survey time period

as of September 2018

Supplementary notes

Total number of drugs 1983−2018 YTD=503; Counts distinct drugs approved with any orphan indication since the passage of the Orphan Drug Act. Includes drug approvals through Aug 2018.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Orphan drugs "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Orphan drugs

Rare diseases

4

Market overview

5

Companies

4

Products

6

Research and development

6

Further related statistics

17

Further Content: You might find this interesting as well

Statistics

Topics

Orphan drugsGlobal pharmaceutical industryPharmaceutical industry in the U.S.Top pharmaceutical drugsDiseases
All features, all contents, at all times: Learn more about our professional solutions.

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.